अApnaFunda
Menu

NAVIN FLUORINE INTERNATIONAL L (NAVINFLUOR)

Process Industries · Chemicals: Specialty · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.80 / 100
Profitability 91Growth 85Balance sheet 64
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.87 / 100
Price 84Earnings 91FII/DII 88

Passes these screensQuality CompounderHigh MomentumDebt-light & profitableConsistent compoundersNear 52-week high

Compare withLINDE INDIACOROMANDEL INTERNATIONAL LIMITGUJARAT FLUOROCHEMICALS

Share price

Closing priceAdjusted for splits and bonus issues.

₹9,115 latest close · +20.7% over the last 90 sessions

₹8,000₹9,000Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹8,000₹9,000Jul 3Sep 4Nov 9

₹9,115 month-end · +58.9% over 12 months

₹6,000₹8,000Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹6,000₹8,000Nov '25May '26Nov '26

₹9,115 month-end · +146.3% over 3 years

₹4,000₹6,000₹8,000Nov '23Jun '24Jan '25Sep '25Apr '26Nov '26 ₹4,000₹6,000₹8,000Nov '23May '25Nov '26

₹9,115 month-end · +1349.1% since Jan '19

₹0₹2,500₹5,000₹7,500Jan '19Aug '20Mar '22Sep '23Apr '25Nov '26 ₹0₹2,500₹5,000₹7,500Jan '19Dec '22Nov '26

52-week range ₹5440.00 to ₹9245.00 · 1-year volatility 34.7%

Was the rally earned?

+59%share price, 1 yearLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 98 points, but investors now pay less per rupee of profit (P/E 80.2x to 59.2x), which took 39 points back.
  • The share count rose 3%.
Net profit growth: +102 pts. Points of the price return explained by net profit growing (or shrinking).+102 ptsNet profit growthP/E change: −39 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−39 ptsP/E changeShare count change: −4 pts. Points of the price return explained by the share count changing. More shares count against the price.−4 ptsShare count changeShare price: +59%+59%Share priceNet profit growth: +102 pts. Points of the price return explained by net profit growing (or shrinking).+102ProfitP/E change: −39 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−39P/EShare count change: −4 pts. Points of the price return explained by the share count changing. More shares count against the price.−4SharesShare price: +59%+59%Share price
Net profit growth+102 ptsNet profit rose about 123%, which lifts the price.
P/E change-39 ptsThe P/E fell from 80.2x to 59.2x, which lowers the price.
Share count change-4 ptsShare count rose 3%, which lowers the price.
+146%share price, 3 yearsEarnings-driven

Mostly yes.

  • Per-share earnings added 115 points to the rise, while the multiple moved less (P/E 48.9x to 59.2x).
  • The share count rose 4%.
Net profit growth: +121 pts. Points of the price return explained by net profit growing (or shrinking).+121 ptsNet profit growthP/E change: +31 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+31 ptsP/E changeShare count change: −6 pts. Points of the price return explained by the share count changing. More shares count against the price.−6 ptsShare count changeShare price: +146%+146%Share priceNet profit growth: +121 pts. Points of the price return explained by net profit growing (or shrinking).+121ProfitP/E change: +31 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+31P/EShare count change: −6 pts. Points of the price return explained by the share count changing. More shares count against the price.−6SharesShare price: +146%+146%Share price
Net profit growth+121 ptsNet profit rose about 111%, which lifts the price.
P/E change+31 ptsThe P/E rose from 48.9x to 59.2x, which lifts the price.
Share count change-6 ptsShare count rose 4%, which lowers the price.
+144%share price, 5 yearsLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 175 points, but investors now pay less per rupee of profit (P/E 71.9x to 59.2x), which took 31 points back.
  • The share count rose 4%.
Net profit growth: +181 pts. Points of the price return explained by net profit growing (or shrinking).+181 ptsNet profit growthP/E change: −31 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−31 ptsP/E changeShare count change: −5 pts. Points of the price return explained by the share count changing. More shares count against the price.−5 ptsShare count changeShare price: +144%+144%Share priceNet profit growth: +181 pts. Points of the price return explained by net profit growing (or shrinking).+181ProfitP/E change: −31 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−31P/EShare count change: −5 pts. Points of the price return explained by the share count changing. More shares count against the price.−5SharesShare price: +144%+144%Share price
Net profit growth+181 ptsNet profit rose about 206%, which lifts the price.
P/E change-31 ptsThe P/E fell from 71.9x to 59.2x, which lowers the price.
Share count change-5 ptsShare count rose 4%, which lowers the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with LINDE INDIA

How rough has the ride been?

Maximum drawdown-39.7%recovered 2025-07
1-year volatility34.7%annualised
Beta vs sector index0.923-year daily, correlation 0.48
Volume spikes2last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%2020202120222023202420252026−38.1% 0%−20%−40%2020202220242026−38.1%
Largest drawdowns

-39.7% (2023-04 peak to 2024-03 low, recovered 2025-07)

-30.0% (2020-02 peak to 2020-03 low, recovered 2020-04)

-24.6% (2019-04 peak to 2019-07 low, recovered 2019-09)

Most recent volume spikes

2026-08-07: 5.1x the 50-day median, price -4.4% that day

2026-08-06: 33.1x the 50-day median, price +13.7% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

59.2xP/E todayWithin its usual range
Against its own history47th percentile
CheapestMedian 60.8xDearest

Usual range 23.9x to 80.5x since 2019-01.

Against Process Industries59.2x vs 18.1x
This company
59.2x
Sector median
18.1x

227% above the Process Industries median.

6.8x35.0x63.2x91.4xJan '19Aug '20Mar '22Oct '23May '25Nov '266.8x35.0x63.2x91.4xJan '19Sep '21May '24Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProcess Industries median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Process Industries is valued

Where does it rank among Process Industries peers?

Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE84th▲ 33 pts vs a year ago
  • Op. margin98thflat vs a year ago
  • Revenue growth92nd▲ 13 pts vs a year ago
  • EPS growth89th▲ 14 pts vs a year ago
  • Debt/equity ↓54th▲ 15 pts vs a year ago
  • Cash cycle ↓76th▲ 17 pts vs a year ago
  • P/E ↓13th▲ 4 pts vs a year ago
  • 12M momentum92nd▼ 3 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Process Industries sector page Watch it move against Process Industries in the Observatory

What is the price implying?

~38%annual earnings growth implied by the priceAbove delivered growth

At normalised P/E (five-year average earnings) of 125.4x, a holder earning 12%/yr needs earnings to grow about 37.8%/yr for 10 years, then trade at 15x.

Delivered14.8%/yrEPS, last 10 fiscal years · 3-yr avg to 3-yr avg
Gap+23.1 ptsimplied minus delivered
Rank102ndmost demanding of 856

Over time

Implied growth by month (solid) and delivered growth (dashed).

0%19%38% Jan 2019Nov 2026 0%19%38% Jan 2019Nov 2026

Change the assumptions

Exit P/E / return11%12%13%
12x39.6%40.8%42.1%
15x36.6%37.8%39.1%
20x32.8%34.0%35.2%

Drag a slider to test other assumptions

Implied: 37.8%/yr

Looking back

  • Jan 2020Price implied 24%/yr; EPS has since grown 24%/yr (7.0 yrs)
  • Jan 2021Price implied 27%/yr; EPS has since grown 8%/yr (6.0 yrs)
  • Jan 2022Price implied 32%/yr; EPS has since grown 21%/yr (5.0 yrs)

Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.

What prices imply across Process Industries The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹9115.00
P/E
59.2x
ROCE
21.0%
Market Cap
₹46773 cr
Revenue (TTM)
₹3633 cr
P/S
12.9x
P/B
11.8x
ROE
19.9%
Operating Margin
34.0%
Debt / Equity
0.3x
Promoter Holding
27.1%
12M Momentum
58.9%

52-week range

₹5440.00₹9245.00
97% of the way from its 52-week low to its high

Price risk

1Y volatility
34.7%
Beta vs sector
1-year daily
0.78

Balance sheet & cash

Interest cover
operating profit ÷ interest
9.7x
Cash from profit, 3Y
operating cash flow ÷ net profit
1.81x
Share count, 1Y
unchanged

Are profits backed by cash?

6 of 7checks within range1 near a threshold
Other income reliance8%Within range

Other income as a share of pre-tax profit (trailing twelve months): 7.6%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate24%Within range

Median quarterly effective tax rate over about 2.5 years: 24.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion1.81xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 1.81x (cash from operations ₹2,215 cr, net profit ₹1,223 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow3 of 5 yrsNear threshold

Fiscal years with positive free cash flow in the last 5: 3. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history-8 daysWithin range

Debtor days are below the median of the previous three fiscal years by 8 days (83 vs 91). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress4% of fixed assetsWithin range

Capital work-in-progress is 4% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+22 days / 2 yrsWithin range

Days payable changed by +22 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 3 years, FIIs added 4.5 pts; DIIs added 2.4 pts; promoters trimmed 1.7 pts.
  • The number of shareholders fell from 1.5 lakh to 1.4 lakh (-6%) between Sep 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupSep '23Jun '26Change
Promoters28.8%27.1%-1.7 pts
FIIs19.2%23.7%+4.5 pts
DIIs26.0%28.5%+2.4 pts
Public and others26.0%20.7%-5.3 pts

Number of shareholders

1.4 lakhshareholders-6% since Sep '23
1.4L1.5L1.7L1.8L Sep '23Jun '24Mar '25Dec '25Jun '26
Sep '23: 1.5 lakh
Dec '23: 1.7 lakh
Mar '24: 1.8 lakh
Jun '24: 1.7 lakh
Sep '24: 1.7 lakh
Dec '24: 1.6 lakh
Mar '25: 1.4 lakh
Jun '25: 1.4 lakh
Sep '25: 1.4 lakh
Dec '25: 1.4 lakh
Mar '26: 1.4 lakh
Jun '26: 1.4 lakh
 1.4L1.5L1.7L1.8L Sep '23Sep '24Sep '25Jun '26
Sep '23: 1.5 lakh
Dec '23: 1.7 lakh
Mar '24: 1.8 lakh
Jun '24: 1.7 lakh
Sep '24: 1.7 lakh
Dec '24: 1.6 lakh
Mar '25: 1.4 lakh
Jun '25: 1.4 lakh
Sep '25: 1.4 lakh
Dec '25: 1.4 lakh
Mar '26: 1.4 lakh
Jun '26: 1.4 lakh

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−16.4%typical 12-month return vs the marketBelow the base rate
  • We found 50 past situations where a non-financial company looked like NAVIN FLUORINE INTERNATIONAL L today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −28% to −2% vs the market, against −4% for all non-financial companies in the same months.
  • The analogs' median sat below that base rate (gap −12.8%, 80% range −20.4% to −8.9%), but the matches cluster in only 6 distinct 12-month windows.

Where the 50 outcomes landed

−60%−40%−20%0%+20%+40%+60%
COHANCE · Mar 2025: −73.1% vs market
MTARTECH · Aug 2023: −49.6% vs market
GRANULES · Oct 2020: −49.4% vs market
IPCALAB · Oct 2020: −42.0% vs market
THERMAX · May 2024: −40.4% vs market
VENUSPIPES · Mar 2024: −38.4% vs market
PVRINOX · Jan 2020: −38.0% vs market
FLUOROCHEM · Sep 2022: −33.4% vs market
EPL · Jul 2020: −32.8% vs market
POLYMED · Oct 2024: −32.2% vs market
METROBRAND · Nov 2023: −30.3% vs market
AFFLE · Jun 2025: −29.1% vs market
SYNGENE · Dec 2020: −28.2% vs market
SFL · Nov 2021: −27.6% vs market
TORNTPHARM · Jul 2020: −26.4% vs market
EIHOTEL · Mar 2024: −24.1% vs market
COFORGE · Jun 2025: −24.0% vs market
JSWINFRA · Mar 2025: −22.6% vs market
FORTIS · Sep 2025: −21.0% vs market
INDHOTEL · Dec 2024: −20.2% vs market
DOMS · Mar 2025: −17.9% vs market
KPITTECH · Oct 2023: −17.9% vs market
ALKEM · Jul 2020: −17.2% vs market
APLLTD · Apr 2020: −17.0% vs market
JBCHEPHARM · Apr 2024: −16.9% vs market
BIOCON · Mar 2020: −15.9% vs market
TASTYBITE · Jun 2020: −15.8% vs market
FINEORG · May 2022: −15.4% vs market
PIIND · Oct 2020: −14.5% vs market
MEDANTA · Nov 2023: −13.1% vs market
MAXHEALTH · Jun 2025: −11.7% vs market
NH · Jun 2025: −9.3% vs market
CHOICEIN · Oct 2025: −8.9% vs market
ROLEXRINGS · Sep 2022: −8.7% vs market
RAINBOW · May 2023: −8.4% vs market
SRF · Mar 2022: −5.2% vs market
ZYDUSLIFE · Jul 2020: −3.7% vs market
TEGA · Oct 2024: −1.5% vs market
LAURUSLABS · May 2021: +0.3% vs market
THYROCARE · Oct 2025: +3.5% vs market
KIMS · May 2025: +8.5% vs market
TRENT · Jun 2024: +11.1% vs market
VIJAYA · Sep 2024: +13.0% vs market
CGPOWER · May 2023: +14.1% vs market
SOLARINDS · Dec 2022: +20.8% vs market
PERSISTENT · Oct 2023: +25.2% vs market
ASTRAL · Mar 2020: +27.7% vs market
VBL · Mar 2023: +35.7% vs market
KAYNES · Feb 2024: +46.2% vs market
ACUTAAS · Jan 2025: +51.2% vs market
Similar setups −16.4%All companies −3.6%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge

Similar setups' median
−16.4%
All companies' median
−3.6%
Beat the market
24% vs 46%

50 past situations · 50 companies · 32 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
SOLARINDS
Process Industries		 Dec 2022 90x25% +81%0% +21%
FLUOROCHEM
Process Industries		 Sep 2022 55x20% +106%0% −33%
TRENT
Retail Trade		 Jun 2024 131x24% +211%0% +11%
POLYMED
Health Technology		 Oct 2024 102x24% +105%0% −32%
SRF
Process Industries		 Mar 2022 66x18% +148%−1% −5%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
PIIND
Process Industries		 Oct 2020 67x23% +54%0% −15%
MAXHEALTH
Health Services		 Jun 2025 115x15% +36%0% −12%
APLLTD
Health Technology		 Apr 2020 24x23% +33%−9% −17%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: P/E, 12-month momentum and interest cover. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to NAVIN FLUORINE INTERNATIONAL L. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

GLOBAL HEALTHMEDANTA
Health Services
79%similar
revenue growthdebt/equity
NEULAND LABORATORIESNEULANDLAB
Health Technology
78%similar
operating marginP/E
INDIAN HOTELS COINDHOTEL
Consumer Services
72%similar
P/Erevenue growth
RADICO KHAITANRADICO
Consumer Non-Durables
72%similar
market capvolatility
SAI LIFE SCIENCESSAILIFE
Health Technology
68%similar
market capROCE
HIMADRI SPECIALITY CHEMHSCL
Process Industries
50%similar
ROCEmarket cap
PRIVI SPECIALITY CHEMICALSPRIVISCL
Process Industries
50%similar
ROCEvolatility
SHAILY ENGINEERING PLASTICS LTSHAILY
Process Industries
49%similar
revenue growthoperating margin

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Apr '23

  1. AugPriceVolume reached 33.1x its 50-day median on 2026-08-06; price +13.7% that day.
  2. JunPeer rankMoved into the top quartile of Process Industries on ROCE (from the 3rd quartile).
  3. AprPriceVolume reached 14.9x its 50-day median on 2026-04-30; price +0.9% that day.
  4. FebPeer rankSlipped to the 3rd quartile of Process Industries on ROCE (from the 2nd quartile).
  5. FebPriceVolume reached 12.7x its 50-day median on 2026-02-10; price -3.9% that day.
  6. OctPriceVolume reached 69.0x its 50-day median on 2025-10-31; price +14.3% that day.
  7. SepPeer rankMoved into the top quartile of Process Industries on EPS growth (from the 2nd quartile).
  8. JulPriceRegained the 2023-04 peak, 16 months after the low.
Show 22 earlier events
  1. JulPriceVolume reached 11.2x its 50-day median on 2025-07-31; price -2.7% that day.
  2. JunResultsYear-on-year EPS growth turned positive.
  3. JunInstitutionsFII + DII holding rose 3.8 pts over 2 quarters to 50.2%.
  4. JunPeer rankMoved into the 2nd quartile of Process Industries on EPS growth (from the 3rd quartile).
  5. JunDividendDividend payout cut from 27% to 12% of profit.
  6. AprValuationP/E crossed above the 90th percentile of its own history to date (84.9x).
  7. AprPriceVolume reached 7.3x its 50-day median on 2025-04-25; price +2.5% that day.
  8. JanPriceVolume reached 38.5x its 50-day median on 2025-01-09; price +9.5% that day.
  9. OctPriceVolume reached 6.5x its 50-day median on 2024-10-24; price +3.1% that day.
  10. SepResultsRevenue (TTM) reached a new high of ₹2,098 cr.
  11. JulPriceVolume reached 5.3x its 50-day median on 2024-07-31; price +0.8% that day.
  12. JunResultsYear-on-year EPS growth turned negative.
  13. JunPeer rankSlipped to the 3rd quartile of Process Industries on EPS growth (from the top quartile).
  14. AprPriceVolume reached 5.8x its 50-day median on 2024-04-10; price +6.2% that day.
  15. MarPriceFell 40% from the Apr 2023 peak to the Mar 2024 low.
  16. FebPriceVolume reached 16.6x its 50-day median on 2024-02-07; price -5.2% that day.
  17. OctPriceVolume reached 16.0x its 50-day median on 2023-10-05; price -3.4% that day.
  18. SepPriceVolume reached 29.7x its 50-day median on 2023-09-29; price -13.6% that day.
  19. JunResultsRevenue (TTM) reached a new high of ₹2,077 cr.
  20. JunPeer rankMoved into the top quartile of Process Industries on EPS growth (from the 3rd quartile).
  21. MayPriceVolume reached 8.4x its 50-day median on 2023-05-15; price -1.1% that day.
  22. AprValuationP/E crossed above the 90th percentile of its own history to date (91.4x).

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history60 months · 2021-12 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1159.2x₹3633 cr19.9%21.0%0.3x
2026-1056.3x₹3633 cr19.9%21.0%0.3x
2026-0953.5x₹3633 cr19.9%21.0%0.3x
2026-0866.6x₹3313 cr16.7%21.0%0.3x
2026-0758.1x₹3313 cr16.7%21.0%0.3x
2026-0659.0x₹3313 cr16.7%21.0%0.3x
2026-0566.1x₹3076 cr20.8%11.0%0.6x
2026-0463.2x₹3076 cr20.8%11.0%0.6x
2026-0357.1x₹3076 cr20.8%11.0%0.6x
2026-0270.6x₹2790 cr16.9%11.0%0.6x
2026-0168.8x₹2790 cr16.9%11.0%0.6x
2025-1266.8x₹2790 cr16.9%11.0%0.6x
2025-1180.2x₹2551 cr13.5%11.0%0.6x
2025-1079.6x₹2551 cr13.5%11.0%0.6x
2025-0964.6x₹2551 cr13.5%11.0%0.6x
2025-0880.6x₹2350 cr11.0%11.0%0.6x
2025-0786.7x₹2350 cr11.0%11.0%0.6x
2025-0682.8x₹2350 cr11.0%11.0%0.6x
2025-0580.1x₹2251 cr11.1%11.0%0.6x
2025-0484.9x₹2251 cr11.1%11.0%0.6x
2025-0379.1x₹2251 cr11.1%11.0%0.6x
2025-0272.2x₹2145 cr10.8%11.0%0.6x
2025-0179.6x₹2145 cr10.8%11.0%0.6x
2024-1262.3x₹2145 cr10.8%11.0%0.6x
2024-1166.9x₹2098 cr10.9%11.0%0.6x
2024-1063.5x₹2098 cr10.9%11.0%0.6x
2024-0965.6x₹2098 cr10.9%11.0%0.6x
2024-0860.5x₹2065 cr11.3%11.0%0.6x
2024-0769.7x₹2065 cr11.3%11.0%0.6x
2024-0665.5x₹2065 cr11.3%11.0%0.6x
2024-0542.1x₹2077 cr17.2%20.0%0.4x
2024-0445.2x₹2077 cr17.2%20.0%0.4x
2024-0341.2x₹2077 cr17.2%20.0%0.4x
2024-0239.9x₹2077 cr17.2%20.0%0.4x
2024-0145.2x₹2077 cr17.2%20.0%0.4x
2023-1250.9x₹2077 cr17.2%20.0%0.4x
2023-1148.9x₹2077 cr17.2%20.0%0.4x
2023-1045.4x₹2077 cr17.2%20.0%0.4x
2023-0949.8x₹2077 cr17.2%20.0%0.4x
2023-0860.8x₹2077 cr17.2%20.0%0.4x
2023-0756.4x₹2077 cr17.2%20.0%0.4x
2023-0659.5x₹2077 cr17.2%20.0%0.4x
2023-0587.9x₹1453 cr14.3%19.0%0.1x
2023-0491.4x₹1453 cr14.3%19.0%0.1x
2023-0380.4x₹1453 cr14.3%19.0%0.1x
2023-0277.8x₹1453 cr14.3%19.0%0.1x
2023-0174.3x₹1453 cr14.3%19.0%0.1x
2022-1276.6x₹1453 cr14.3%19.0%0.1x
2022-1181.8x₹1453 cr14.3%19.0%0.1x
2022-1085.7x₹1453 cr14.3%19.0%0.1x
2022-0984.6x₹1453 cr14.3%19.0%0.1x
2022-0880.5x₹1453 cr14.3%19.0%0.1x
2022-0782.6x₹1453 cr14.3%19.0%0.1x
2022-0668.8x₹1453 cr14.3%19.0%0.1x
2022-0575.4x₹1179 cr15.8%22.0%0.0x
2022-0475.6x₹1179 cr15.8%22.0%0.0x
2022-0378.5x₹1179 cr15.8%22.0%0.0x
2022-0274.8x₹1179 cr15.8%22.0%0.0x
2022-0175.6x₹1179 cr15.8%22.0%0.0x
2021-1280.5x₹1179 cr15.8%22.0%0.0x

Older months are in the live observatory.

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback